Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Primary prevention of dementia in Alzheimer's disease: A perspective from prevention research in cardiovascular disease and stroke

Alzheimer's and Dementia

Volumn 5, Issue 2, 2009, Pages 149-153

  Fillit, Howard ^a,b   Nash, David T ^c   Shineman, Diana ^a  

^a Alzheimers Drug Discovery Foundation   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN ANTIBODY; BILE ACID SEQUESTRANT; CHOLESTEROL; GLUCOSE; GUANETHIDINE; HEMOGLOBIN A1C; HYDRALAZINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; TAU PROTEIN; THIOCYANATE SODIUM;

ALZHEIMER DISEASE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COMORBIDITY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE MARKER; DRUG EFFICACY; EDITORIAL; ESSENTIAL HYPERTENSION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIFESTYLE MODIFICATION; MEDICAL RESEARCH; OUTCOME ASSESSMENT; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK MANAGEMENT; RISK REDUCTION; SODIUM RESTRICTION;

AGED; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; BIOMEDICAL RESEARCH; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; DISEASE MANAGEMENT; DISEASE PROGRESSION; EARLY DIAGNOSIS; HUMANS; PREVENTIVE MEDICINE; RISK REDUCTION BEHAVIOR; STROKE;

EID: 62849105840     PISSN: 15525260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jalz.2009.01.012     Document Type: Editorial

References (31)

1. Hauber A.B., Johnson F.R., Fillit H., et al. Older Americans' risk-benefit preferences for modifying the course of Alzheimer disease. Alzheimer Dis Assoc Disord (2008 Aug 22) [Epub ahead of print]
2. Fillit H. Drug discovery and the prevention of Alzheimer's disease. Alzheimers Dement 4 1 Suppl. 1 (2008) S26-S28
3. Gerstein H.C., Miller M.E., Byington R.P., Goff Jr. D.C., Bigger J.T., Buse J.B., et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358 (2008) 2545-2559
4. Neeli H., and Rader D.J. Cholesteryl ester transfer protein (CETP) inhibitors: is there life after torcetrapib?. Cardiol Clin 26 (2008) 537-546
5. Banting F.G., Best C.H., Collip J.B., Campbell W.R., and Fletcher A.A. Pancreatic extracts in the treatment of diabetes mellitus: preliminary report. 1922. CMAJ 145 (1991) 1281-1286
6. Holmquist W.R., and Schroeder W.A. Properties and partial characterization of adult human hemoglobin A1C. Biochim Biophys Acta 82 (1964) 639-641
7. Duckworth W., Abraira C., Moritz T., Reda D., Emanuele N., Reaven P.D., et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360 (2009) 129-139
8. Jaikaran E.T., and Clark A. Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology. Biochim Biophys Acta 1537 (2001) 179-203
9. Esunge P.M. From blood pressure to hypertension: the history of research. J R Soc Med 84 (1991) 621
10. Freis E.D. The Veterans Administration cooperative study on antihypertensive agents. Implications for stroke prevention. Stroke 5 (1974) 76-77
11. Freis E.D. Recent advances in the medical treatment of essential hypertension with particular reference to drugs. Med Clin North Am 32 Bost Number (1948) 1247-1258
12. Pearce K.A., Furberg C.D., Psaty B.M., and Kirk J. Cost-minimization and the number needed to treat in uncomplicated hypertension. Am J Hypertens 11 (1998) 618-629
13. Berenson G.S., Srinivasan S.R., Dalferes Jr. E.R., Puyau F.A., O'Meallie L.P., Hall R.J., et al. Serum lipoproteins and coronary heart disease. Am J Cardiol 34 (1974) 588-593
14. Rifkind B.M., and Levy R.I. Does hypolipidemic therapy prevent coronary heart disease?. Cardiovasc Clin 6 (1974) 1-8
15. Levy R.I., Fredrickson D.S., Stone N.J., Bilheimer D.W., Brown W.V., Glueck C.J., et al. Cholestyramine in type II hyperlipoproteinemia. A double-blind trial. Ann Intern Med 79 (1973) 51-58
16. Nash D.T., Caldwell N., and Ancona D. Accelerated coronary artery disease arteriographically proved: analysis of risk factors. N Y State J Med 74 (1974) 947-950
17. Nash D.T., Gensini G., Simon H., Arno T., and Nash S.D. The Erysichthon syndrome. Progression of coronary atherosclerosis and dietary hyperlipidemia. Circulation 56 (1977) 363-365
18. Nash D.T., Gensini G.G., and Esente P. Regression of coronary artery lesions during lipid lowering therapy, demonstrated by scheduled serial arteriography. Int J Cardiol 3 (1983) 257-260
19. Nash D.T. Physician inertia in dealing with hypercholesterolemia discovered during hospitalization. Am J Cardiol 65 (1990) 1410
20. Nash D.T. Statins. Evidence of effectiveness in older patients. Geriatrics 58 (2003) 35-42
21. Daviglus M.L., Lloyd-Jones D.M., and Pirzada A. Preventing cardiovascular disease in the 21st century: therapeutic and preventive implications of current evidence. Am J Cardiovasc Drugs 6 (2006) 87-101
22. LaRosa J.C., He J., and Vupputuri S. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA 282 (1999) 2340-2346
23. Sachdeva A., Cannon C.P., Deedwania P.C., Labresh K.A., Smith Jr. S.C., Dai D., et al. Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines. Am Heart J 157 (2009) 111-117
24. Alexander K.P., Cowper P.A., Kempf J.A., Lytle B.L., and Peterson E.D. Profile of chronic and recurrent angina pectoris in a referral population. Am J Cardiol 102 (2008) 1301-1306
25. Fillit H., Nash D.T., Rundek T., and Zuckerman A. Cardiovascular risk factors and dementia. Am J Geriatr Pharmacother 6 (2008) 100-118
26. Waters D.D., LaRosa J.C., Barter P., Fruchart J.C., Gotto Jr. A.M., Carter R., et al. Effects of high-dose atorvastatin on cerebrovascular events in patients with stable coronary disease in the TNT [treating to new targets] study. J Am Coll Cardiol 48 (2006) 1793-1799
27. Schneider J.A., Boyle P.A., Arvanitakis Z., Bienias J.L., and Bennett D.A. Subcortical infarcts, Alzheimer's disease pathology, and memory function in older persons. Ann Neurol 62 (2007) 59-66
28. Schneider J.A., Arvanitakis Z., Bang W., and Bennett D.A. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 69 (2007) 2197-2204
29. Tomlinson B.E., Blessed G., and Roth M. Observations on the brains of demented old people. J Neurol Sci 11 (1970) 205-242
30. Glenner G.G., and Wong C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein 4. Biochem Biophys Res Commun 120 (1984) 885-890
31. Grundke-Iqbal I., Iqbal K., Quinlan M., Tung Y.C., Zaidi M.S., and Wisniewski H.M. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem 261 (1986) 6084-6089